TITLE

HYPOGLYCEMIC AGENTS, ORAL

PUB. DATE
January 2007
SOURCE
Davis's Drug Guide for Nurses, 10th edition;2007, p616
SOURCE TYPE
Book
DOC. TYPE
Article
ABSTRACT
The article presents a nursing guide for several oral hypoglycemic agents, including glimepiride, glipizide, and glyburide, drugs used for controlling blood glucose in patients with non-insulin-dependent diabetes mellitus. The mechanism of action of the drug is discussed. Information on its pharmacokinetics is provided. Precautionary measures and contraindications for its use are cited. Adverse effects a patient who is taking the drug may manifest are also mentioned. Nursing assessment and interventions are discussed.
ACCESSION #
22441155

 

Related Articles

  • miglitol.  // Davis's Drug Guide for Nurses, 10th edition;2007, p798 

    The article presents a nursing guide for miglitol, a drug used for management of non-insulin-dependent diabetes mellitus. The mechanism of action of the antidiabetic agent is discussed. Information on its pharmacokinetics is provided. Precautionary measures and contraindications for its use are...

  • Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M). AHRÉN, BO; LEGUIZAMO DIMAS, ANICETO; MIOSSEC, PATRICK; SAUBADU, STÉPHANE; ARONSON, RONNIE // Diabetes Care;Sep2013, Vol. 36 Issue 9, p2543 

    OBJECTIVE--To examine the efficacy and safety of lixisenatide (20 µg once daily, administered before the morning or evening meal) as add-on therapy in patients with type 2 diabetes insufficiently controlled with metformin alone. RESEARCH DESIGN AND METHODS--This was a 24-week, randomized,...

  • Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Kolterman, Orville G.; Kim, Dennis D.; Shen, Larry; Ruggles, James A.; Nielsen, Loretta L.; Fineman, Mark S.; Baron, Alain D. // American Journal of Health-System Pharmacy;1/15/2005, Vol. 62 Issue 2, p173. 

    Purpose. The pharmacology and tolerability of exenatide in patients with type 2 diabetes mellitus were studied. Methods. Two randomized, single-blind, placebo-controlled studies were conducted. Treatment with oral antidiabetic agents was stopped 14 days before study initiation. In the first...

  • The Pharmacogenetics of Type 2 Diabetes: A Systematic Review. Maruthur, Nisa M.; Gribble, Matthew O.; Bennett, Wendy L.; Bolen, Shari; Wilson, Lisa M.; Balakrishnan, Poojitha; Sahu, Anita; Bass, Eric; Kao, W. H. Linda; Clark, Jeanne M. // Diabetes Care;Mar2013, Vol. 37 Issue 3, p876 

    OBJECTIVE We performed a systematic review to identify which genetic variants predict response to diabetes medications. RESEARCH DESIGN AND METHODS We performed a search of electronic databases (PubMed, EMBASE, and Cochrane Database) and a manual search to identify original, longitudinal studies...

  • Changing the Treatment Paradigm for Type 2 Diabetes. Del Prato, Stefano; Penno, Giuseppe; Miccoli, Roberto // Diabetes Care;Nov2009 Supplement, Vol. 32, pS217 

    The authors cite the hindrances in type 2 diabetes treatment to demonstrate the need for change. Based on studies, they say that long-term adherence to diet and exercise is needed to ensure their effectiveness in glycemic control. They add that no hypoglycemic agent is available that can...

  • Pharmacokinetics, efficacy and safety of aleglitazar for the treatment of type 2 diabetes with high cardiovascular risk.  // Current Medical Literature: Diabetes;2011, Vol. 28 Issue 4, p136 

    The article comments on a study regarding the pharmocokinetics, efficacy and safety of the anti-diabetic drug aleglitazar for treating type 2 diabetes patients with concomitantly high cardiovascular risk in terms of improvements such as in glycemia, triglycerides and blood pressure.

  • ADVERSE EFFECTS OF METFORMIN IN COMBINATION WITH GLIMEPIRIDE AND GLIBENCLAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Pravinkumar, V. Ingle; Gokul, S. Talele // Asian Journal of Pharmaceutical & Clinical Research;Jan-Mar2012 Supplement, p108 

    In type 2 diabetes mellitus, it is considered that the lowered insulin secretion and the lowered insulin sensitivity cause hyperglycaemia. Sulfonylureas have strong blood-glucose lowering effect by stimulating insulin secretion and have been widely used in the treatment of type 2 diabetes....

  • THIAZOLIDINEDIONES.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p786 

    The article presents information on thiazolidinediones, an antidiabetic drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • THIAZOLIDINEDIONES.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p796 

    The article presents information on thiazolidinediones, a drug used for the treatment of type II non-insulin-dependent diabetes mellitus. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics